Tijaria Polypipes Q1FY27: Loss widens, revenue nil

Key takeaway from the Q1FY27 filing

Tijaria Polypipes Limited reported a wider standalone loss for the quarter ended June 30, 2026 (Q1FY27), even as total income increased on the back of other income. The company reported no revenue from operations for the quarter. In one section of the supplied data, the loss is stated as ₹36.11 crore, while another section states the loss as ₹36.11 lakh. The same inconsistency appears for total income, shown as ₹5.29 crore in one place and ₹5.29 lakh in another. This report presents the figures as they appear and normalises them into ₹ crore where possible.

Q1FY27: Net loss widens year-on-year

According to the figures provided, the company posted a standalone net loss of ₹36.11 crore in Q1FY27, compared with a loss of ₹26.62 crore in Q1FY26, implying a year-on-year widening of 35.6%. The company’s total expenses in the same table rose to ₹41.40 crore from ₹28.76 crore, an increase of 43.9%. Revenue from operations was reported at ₹0 crore for both Q1FY27 and Q1FY26. With operations not contributing to income, profitability continued to depend on non-operating lines.

A separate portion of the provided text describes the same quarter’s loss as ₹36.11 lakh (₹0.3611 crore) versus ₹26.62 lakh (₹0.2662 crore) a year ago. It also describes total income as ₹5.29 lakh (₹0.0529 crore) versus ₹2.14 lakh (₹0.0214 crore), stating a 147% year-on-year increase. Both versions point to the same underlying theme: zero operational revenue, higher costs, and a widening loss.

Revenue remains zero, income comes from other sources

The supplied metric table states revenue from operations was ₹0 crore in Q1FY27 and ₹0 crore in Q1FY26. Total income for Q1FY27 is shown as ₹5.29 crore, derived entirely from other income, versus ₹2.14 crore in Q1FY26. This is presented as a 147.2% increase year-on-year in both other income and total income.

The alternative presentation repeats the same structure but in lakh units: total income of ₹5.29 lakh versus ₹2.14 lakh. Irrespective of unit, the narrative remains consistent that the company’s quarterly income was entirely from “other income” rather than pipe or plastics sales.

Expenses and EPS: what changed in the quarter

In the metric table, total expenses are shown at ₹41.40 crore for Q1FY27 versus ₹28.76 crore for Q1FY26. A separate language segment also notes total expenses of ₹41.40 lakh (₹0.4140 crore), attributing them mainly to finance costs and depreciation.

Earnings per share (EPS) stood at a loss of ₹0.13 per equity share of face value ₹10 each, compared with a loss of ₹0.09 per share in Q1FY26. The quarterly table also shows adjusted EPS (Rs) at -0.13 for Jun 2026.

Board approval and corporate actions mentioned

The Board approved the results on August 14, 2026, as stated in the text. The supplied content also mentions that the financial results were reviewed by the Audit Committee and approved by the Board of Directors on the same date.

Separately, the text notes that the Board would accept the resignation of Non-Executive Independent Director Bhairu Singh, effective August 8, 2026, due to other professional engagements.

Nine-month and full-year loss figures cited

For the nine months ended June 30, 2026, the article states the company incurred a cumulative loss of ₹128.72 crore in one place. Elsewhere, it states a cumulative net loss of ₹128.72 lakh (₹1.2872 crore) for the full fiscal year ended March 31, 2026.

The supplied FY26 summary also says Tijaria Polypipes reported a net loss of ₹128.72 lakh for FY26 with zero operational revenue, and recorded total income of ₹22.29 lakh (₹0.2229 crore), solely from other income, compared with ₹29.78 lakh (₹0.2978 crore) in the previous year.

Stock price snapshots cited in the text

Multiple price points appear in the supplied content. One line states: “The current share price of Tijaria Polypipes is Rs 6.12.” Another shows “Last | 2:59 PM IST 5.68 +0.13 (+2.34%).” Elsewhere, a quote shows “5.09 +0.35 (+7.38%).” A separate “share analyst review” section states the stock was priced at Rs 4.36, with a 52-week high of Rs 8.00 and a 52-week low of Rs 2.80.

Key numbers at a glance (normalised to ₹ crore)

Why the numbers matter for investors

The consistent signal across the supplied data is that the company reported zero revenue from operations while expenses and losses continued. When total income is entirely driven by other income, quarterly performance can become sensitive to non-operating items rather than demand conditions in the HDPE pipes or plastics segment.

The year-on-year widening of loss, alongside higher expenses, is the primary change highlighted for Q1FY27. The board approval date of August 14, 2026, provides a clear reference point for when these numbers were formally taken on record.

Conclusion

Tijaria Polypipes’ Q1FY27 results show a wider loss and nil operating revenue, with total income coming entirely from other income. The Board approved the results on August 14, 2026, and the same update also referenced an independent director’s resignation effective August 8, 2026.